Tian Xia

机构：Tianjin University of Traditional Chinese Medicine, University of California, Los Angeles, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Hangzhou Medical College · ORCID：0000-0002-9665-5858

发表论文 79 篇 · 总被引 1973 次 · h-index 26

代表论文

• Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments (2022 · Nature Communications · 被引 74)
• Microneedles loaded with cerium-manganese oxide nanoparticles for targeting macrophages in the treatment of rheumatoid arthritis (2024 · Journal of Nanobiotechnology · 被引 48)
• R-Judge: Benchmarking Safety Risk Awareness for LLM Agents (2024 · 被引 34)
• NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway (2023 · Nature Communications · 被引 22)
• Aloe-emodin destroys the biofilm of Helicobacter pylori by targeting the outer membrane protein 6 (2023 · Microbiological Research · 被引 20)
• Chemotactic recruitment of genetically engineered cell membrane-camouflaged metal−organic framework nanoparticles for ischemic osteonecrosis treatment (2024 · Acta Biomaterialia · 被引 18)